10
Participants
Start Date
July 31, 2010
Primary Completion Date
July 31, 2012
Study Completion Date
August 31, 2012
Ranibizumab 2 mg
intravitreal injections of ranibizumab once a month, times 3.
0.5 mg Ranibizumab
6 intravitreal injections of 0.5 mg Ranibizumab every 2 weeks x 3 months.
New England Retina Associates, Hamden
Collaborators (1)
Genentech, Inc.
INDUSTRY
New England Retina Associates
OTHER